Skip to main content

vanquish

NDC 42364-0011 · DSE Healthcare Solutions, LLC

FDA lists marketing as ended on 2026-08-31.
Generic nameacetaminophen, aspirin, and caffeine
Dosage formTABLET, COATED
RouteORAL
Active ingredient(s)ACETAMINOPHEN, ASPIRIN, CAFFEINE
Strength194; 227; 33 mg/1; mg/1; mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
Marketing categoryOTC MONOGRAPH DRUG

Packages

42364-0011-1 — 1 BOTTLE in 1 CARTON (42364-0011-1) / 100 TABLET, COATED in 1 BOTTLE

42364-0011-2 — 1 BOTTLE in 1 CARTON (42364-0011-2) / 120 TABLET, COATED in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

41520-712 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 41520-713 — acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl, 41520-786 — Acetaminophen, 41520-800 — Acetaminophen, 41520-919 — Acetaminophen, 41520-956 — Acetaminophen, Diphenhydramine HCl, 41520-984 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 41520-985 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 42291-116 — Aspirin and Extended-Release Dipyridamole, 42291-181 — Butalbital, Acetaminophen, and Caffeine, 42364-2208 — acetaminophen, aspirin, and caffeine, 42507-001 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 42507-006 — Aspirin, 42507-018 — ASPIRIN, 42507-020 — Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl, 42507-056 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 42507-080 — ASPIRIN, 42507-095 — Acetaminophen and Diphenhydramine Hydrochloride, 42507-103 — Acetaminophen, 42507-148 — Acetaminophen, +4118 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels